Focal Laser Ablation for the Treatment of Focal Low-Intermediate Risk Prostate Cancer
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An RCT to Compare Early Continence Recovery After RARP With or Without Sustainable Functional Urethral Reconstruction
- Status
- COMPLETED
- Phase
- NA
Changes in Body Composition With Patients Under Androgen Deprivation Therapy
- Status
- UNKNOWN
- Phase
- N/A
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II)
- Status
- RECRUITING
- Phase
- NA
Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong
- Status
- UNKNOWN
- Phase
- NA
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The Registry of Oncology Outcomes Associated with Testing and Treatment
- Status
- COMPLETED
- Phase
- N/A
Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients Undergoing Prostatectomy
- Status
- WITHDRAWN
- Phase
- NA
INTREPId (INTermediate Risk Erection PreservatIon Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Influence of EMT on CTCs and Disease Progression in Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
Nivolumab in Biochemically Recurrent dMMR Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
- Status
- UNKNOWN
- Phase
- N/A
A Registry for Hereditary Cancer Risk Assessment and Genetic Testing
- Status
- COMPLETED
- Phase
- N/A
Robot-assisted vs Laparoscopic Radical Prostatectomy for Prostate Cancer Treatment
- Status
- UNKNOWN
- Phase
- NA
Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2